Co-Authors
This is a "connection" page, showing publications co-authored by Martin Siegemund and Sarah Tschudin-Sutter.
Connection Strength
0.470
-
Ninety-day outcome of patients with severe COVID-19 treated with tocilizumab - a single centre cohort study. Swiss Med Wkly. 2021 08 02; 151:w20550.
Score: 0.060
-
Direct Comparison of Clinical Characteristics, Outcomes, and Risk Prediction in Patients with COVID-19 and Controls-A Prospective Cohort Study. J Clin Med. 2021 06 17; 10(12).
Score: 0.059
-
Association of Frailty with Adverse Outcomes in Patients with Suspected COVID-19 Infection. J Clin Med. 2021 Jun 02; 10(11).
Score: 0.059
-
Comparison of Acute Kidney Injury in Patients with COVID-19 and Other Respiratory Infections: A Prospective Cohort Study. J Clin Med. 2021 May 25; 10(11).
Score: 0.059
-
SARS-CoV-2 outbreak in a tri-national urban area is dominated by a B.1 lineage variant linked to a mass gathering event. PLoS Pathog. 2021 03; 17(3):e1009374.
Score: 0.058
-
Prevalence and outcome of dysnatremia in patients with COVID-19 compared to controls. Eur J Endocrinol. 2021 Mar; 184(3):409-418.
Score: 0.058
-
Community-acquired and hospital-acquired respiratory tract infection and bloodstream infection in patients hospitalized with COVID-19 pneumonia. J Intensive Care. 2021 Jan 18; 9(1):10.
Score: 0.058
-
Serum Neurofilament Light Chain Levels in the Intensive Care Unit: Comparison between Severely Ill Patients with and without Coronavirus Disease 2019. Ann Neurol. 2021 03; 89(3):610-616.
Score: 0.058